+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Isocarboxazid"

From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Isocarboxazid is a monoamine oxidase inhibitor (MAOI) used to treat mental disorders such as depression, anxiety, and panic disorder. It works by blocking the breakdown of certain neurotransmitters in the brain, which helps to improve mood and reduce symptoms. Isocarboxazid is usually prescribed when other medications have not been effective. It is generally taken once or twice daily, and side effects may include nausea, dizziness, and insomnia. Isocarboxazid is available in both generic and brand-name forms. Common brand names include Marplan, Enerzer, and Nardil. It is available in tablet, capsule, and liquid forms. The isocarboxazid market is highly competitive, with many companies offering similar products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, and Eli Lilly. Other companies include AstraZeneca, Novartis, and Sun Pharmaceuticals. Show Less Read more